Carprofen
(right click,save link as to download,it is a temp file,please download as soon as possible, you can also use CTRL+S to save the whole html page)
Basic Info
Common Name | Carprofen(F05661) |
2D Structure | |
FRCD ID | F05661 |
CAS Number | 53716-49-7 |
PubChem CID | 2581 |
Formula | C15H12ClNO2 |
IUPAC Name | 2-(6-chloro-9H-carbazol-2-yl)propanoic acid |
InChI Key | PUXBGTOOZJQSKH-UHFFFAOYSA-N |
InChI | InChI=1S/C15H12ClNO2/c1-8(15(18)19)9-2-4-11-12-7-10(16)3-5-13(12)17-14(11)6-9/h2-8,17H,1H3,(H,18,19) |
Canonical SMILES | CC(C1=CC2=C(C=C1)C3=C(N2)C=CC(=C3)Cl)C(=O)O |
Isomeric SMILES | CC(C1=CC2=C(C=C1)C3=C(N2)C=CC(=C3)Cl)C(=O)O |
Synonyms | Rimadyl Carprofene [INN-French] carprofen 53716-49-7 2-(6-Chloro-9H-carbazol-2-yl)propanoic acid Imadyl Ridamyl Carprofene Carprofeno Carprofenum |
Classifies | Predicted: Pollutant |
Update Date | Nov 13, 2018 17:07 |
Chemical Taxonomy
Kingdom | Organic compounds |
Superclass | Organoheterocyclic compounds |
Class | Indoles and derivatives |
Subclass | Carbazoles |
Intermediate Tree Nodes | Not available |
Direct Parent | Carbazoles |
Alternative Parents | |
Molecular Framework | Aromatic heteropolycyclic compounds |
Substituents | Carbazole - Indole - Aryl chloride - Aryl halide - Benzenoid - Pyrrole - Heteroaromatic compound - Carboxylic acid derivative - Carboxylic acid - Monocarboxylic acid or derivatives - Azacycle - Organochloride - Organohalogen compound - Organic oxygen compound - Organic oxide - Organic nitrogen compound - Carbonyl group - Organonitrogen compound - Organooxygen compound - Hydrocarbon derivative - Organopnictogen compound - Aromatic heteropolycyclic compound |
Description | This compound belongs to the class of organic compounds known as carbazoles. These are compounds containing a three ring system containing a pyrrole ring fused on either side to a benzene ring. |
Properties
Property Name | Property Value |
---|---|
Molecular Weight | 273.716 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 2 |
Complexity | 362 |
Monoisotopic Mass | 273.056 |
Exact Mass | 273.056 |
XLogP | 4 |
Formal Charge | 0 |
Heavy Atom Count | 19 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Isotope Atom Count | 0 |
Covalently-Bonded Unit Count | 1 |
ADMET
Model | Result | Probability |
---|---|---|
Absorption | ||
Blood-Brain Barrier | BBB+ | 0.9742 |
Human Intestinal Absorption | HIA+ | 1.0000 |
Caco-2 Permeability | Caco2+ | 0.5595 |
P-glycoprotein Substrate | Non-substrate | 0.7062 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.9850 |
Non-inhibitor | 0.9319 | |
Renal Organic Cation Transporter | Non-inhibitor | 0.8485 |
Distribution | ||
Subcellular localization | Mitochondria | 0.4735 |
Metabolism | ||
CYP450 2C9 Substrate | Non-substrate | 0.7405 |
CYP450 2D6 Substrate | Non-substrate | 0.8318 |
CYP450 3A4 Substrate | Non-substrate | 0.6389 |
CYP450 1A2 Inhibitor | Inhibitor | 0.6573 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.7193 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9481 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.7037 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.8308 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7940 |
Excretion | ||
Toxicity | ||
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9725 |
Non-inhibitor | 0.8697 | |
AMES Toxicity | Non AMES toxic | 0.9133 |
Carcinogens | Non-carcinogens | 0.8521 |
Fish Toxicity | High FHMT | 0.9695 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9490 |
Honey Bee Toxicity | Low HBT | 0.5577 |
Biodegradation | Not ready biodegradable | 0.9874 |
Acute Oral Toxicity | II | 0.7358 |
Carcinogenicity (Three-class) | Non-required | 0.5366 |
Model | Value | Unit |
---|---|---|
Absorption | ||
Aqueous solubility | -4.4286 | LogS |
Caco-2 Permeability | 1.0471 | LogPapp, cm/s |
Distribution | ||
Metabolism | ||
Excretion | ||
Toxicity | ||
Rat Acute Toxicity | 3.4155 | LD50, mol/kg |
Fish Toxicity | 0.8693 | pLC50, mg/L |
Tetrahymena Pyriformis Toxicity | 0.3069 | pIGC50, ug/L |
MRLs
Food | Product Code | Country | MRLs | Application Date | Notes |
---|---|---|---|---|---|
Other Terrestrial Mammals,Edible Offal | Japan | 1ppm | |||
Cattle,Edible Offal | Japan | 1ppm | |||
Other Terrestrial Mammals,Kidney | Japan | 1ppm | |||
Cattle,Kidney | Japan | 1ppm | |||
Other Terrestrial Mammals,Liver | Japan | 1ppm | |||
Cattle,Liver | Japan | 1ppm | |||
Other Terrestrial Mammals,Fat | Japan | 1ppm | |||
Cattle,Fat | Japan | 1ppm | |||
Other Terrestrial Mammals,Muscle | Japan | 0.5ppm | |||
Cattle,Muscle | Japan | 0.5ppm |
References
Title | Journal | Date | Pubmed ID |
---|---|---|---|
The use of toxicokinetics and exposure studies to show that carprofen in cattle tissue could lead to secondary toxicity and death in wild vultures. | Chemosphere | 2018 Jan | 28985539 |
Sterility and Stability of Diluted Carprofen in a Multidose Vial in theLaboratory Animal Setting. | J Am Assoc Lab Anim Sci | 2017 May 1 | 28535864 |
Effect of sorbitol, single, and multidose activated charcoal administration oncarprofen absorption following experimental overdose in dogs. | J Vet Emerg Crit Care (San Antonio) | 2015 Sep-Oct | 25891141 |
A multiresidue liquid chromatographic/tandem mass spectrometric method for thedetection and quantitation of 15 nonsteroidal anti-inflammatory drugs (NSAIDs) inbovine meat and milk. | Anal Bioanal Chem | 2015 Jun | 25814273 |
Pharmacological effects of a C-phycocyanin-based multicomponent nutraceutical in an in-vitro canine chondrocyte model of osteoarthritis. | Can J Vet Res | 2015 Jul | 26130858 |
Randomised trial of the bioavailability and efficacy of orally administeredflunixin, carprofen and ketoprofen in a pain model in sheep. | Aust Vet J | 2015 Aug | 26220318 |
Short communication: Effects of analgesic use postcalving on cow welfare andproduction. | J Dairy Sci | 2014 Feb | 24290817 |
Determination of non-steroidal anti-inflammatory drugs and their metabolites inmilk by liquid chromatography-tandem mass spectrometry. | Anal Bioanal Chem | 2012 Jul | 22395450 |
Assessment of carprofen and buprenorphine on recovery of mice after surgicalremoval of the mammary fat pad. | J Am Assoc Lab Anim Sci | 2010 Sep | 20858363 |
Confirmatory analysis of non-steroidal anti-inflammatory drugs in bovine milk by high-performance liquid chromatography with fluorescence detection. | J Chromatogr A | 2010 Apr 23 | 20227702 |
Systematic review of the management of canine osteoarthritis. | Vet Rec | 2009 Apr 4 | 19346540 |
Effect of carprofen treatment following experimentally induced Escherichia colimastitis in primiparous cows. | J Dairy Sci | 2005 Jul | 15956299 |
Protective effect of the chondroprotective agent Cosequin DS on bovine articular cartilage exposed in vitro to nonsteroidal antiinflammatory agents. | Vet Ther | 2002 Summer | 19750743 |
Assessment of the postoperative discomfort of intra-auricularly hypophysectomizedrats. | Lab Anim | 2002 Apr | 11943078 |
Effects of butorphanol and carprofen on the minimal alveolar concentration ofisoflurane in dogs. | J Am Vet Med Assoc | 2000 Oct 1 | 11019709 |
Pharmacodynamics and pharmacokinetics of carprofen, a non-steroidal anti-inflammatory drug, in healthy cows and cows with Escherichia coli endotoxin-induced mastitis. | J Vet Pharmacol Ther | 1991 Sep | 1744930 |